Drug Type siRNA |
Synonyms CA 103, CA 103T, CA-103 + [1] |
Target |
Mechanism AR antagonists(Androgen Receptor antagonists), mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Discovery | KR | 20 Apr 2023 | |
Prostatic Hyperplasia | Discovery | KR | 20 Apr 2023 |